Six Belgian racing pigeons 'doped with drugs'

Belgian racing pigeons Pigeon racing and breeding in Belgium generates huge amounts of money

Related Stories

Six racing pigeons in Belgium were found to have been doped with drugs such as cocaine and painkillers, newspapers in the country say.

They said that the doping was revealed when the Belgian pigeon-racing federation sent samples from 20 birds to the National Horseracing Authority of Southern Africa.

The newspapers said that the birds tested positive for numerous drugs.

Pigeon racing in Belgium is a highly lucrative sport.

In May a Belgian racing pigeon called Bolt - named after Olympic gold-winning Jamaican sprinter Usain Bolt - was sold to a Chinese businessman for a world record price of 310,000 euros (£260,000: $400,000).

It was thought that the buyer wanted to use Bolt for breeding more birds.

Correspondents say that the riches and glamour connected with racing pigeons have brought many problems, including thefts from breeders and racketeering.

Reports say that the doping of the birds was only unearthed in South Africa - tests carried out in Belgium did not reveal a problem.

The sport revolves around specially bred and trained pigeons released from a specific location and racing back to their home loft.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Europe stories

RSS

Features

  • PlanesTest of nerve

    WW1 fighter pilots who navigated using a school atlas


  • Pauline Borghese What the butler saw

    Scandalous tales from the British embassy in Paris


  • A baby holds an adult's fingerSmall Data

    The time when the average age of death was zero


  • League of LegendsBattle for glory

    On the ground at League of Legends World Championship's final


  • Vinyl record pressing in AustraliaVinyl vibe

    Getting into the groove with Australia's last record maker


BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.